MIRASOL, F. (2025). Advancing Biotherapy Production with Continuous Manufacturing: RNA modalities will especially benefit from fuller adoption of continuous manufacturing platforms. BioPharm International, 38(2), 19-21.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
MIRASOL, FELIZA. "Advancing Biotherapy Production with Continuous Manufacturing: RNA Modalities Will Especially Benefit from Fuller Adoption of Continuous Manufacturing Platforms."
BioPharm International 38, no. 2 (2025): 19-21.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
MIRASOL, FELIZA. "Advancing Biotherapy Production with Continuous Manufacturing: RNA Modalities Will Especially Benefit from Fuller Adoption of Continuous Manufacturing Platforms."
BioPharm International, vol. 38, no. 2, 2025, pp. 19-21.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.